The rs483145 polymorphism of MC4R gene is not associated with obesity in the Chilean population: Results of GENADIO study.


Journal

Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 05 02 2021
revised: 04 06 2021
accepted: 05 06 2021
pubmed: 16 5 2022
medline: 3 6 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

The melanocortin receptor 4 (MC4R) participates in the control of appetite at the level of the central nervous system, through the leptin-melanocortin pathway. An association between different polymorphisms of the MC4R gene and obesity has been reported. However, there are few studies of the rs483145 single nucleotide polymorphism (SNP) of this gene. To investigate its prevalence and association with adiposity markers in Chilean adults. The prevalence of SNP rs483145, of the MC4R gene, was determined in 259 participants of the GENADIO study (genes, environment, diabetes and obesity) by means of real-time polymerase chain reaction (PCR). The association between the risk allele of MC4R (A) and adiposity markers (body weight, body mass index, fat mass percentage, hip circumference, waist circumference, waist-to-hip ratio) was performed by linear regression analysis and adjusted for confusion variables (socio-demographic and physic activity) using three statistical models. It was determined that the prevalence of the risk allele (A) of the SNP rs483145 of the MC4R gene is 24.5% in the Chilean adult population included in this study, without finding an association with any of the adiposity markers studied, both in adjusted and unadjusted models. The presence of the risk allele of SNP rs483145 of the MC4R gene is not associated with adiposity markers in the Chilean adult population studied. New studies with a bigger sample size will be necessary to confirm these results.

Identifiants

pubmed: 35570141
pii: S2530-0180(22)00066-X
doi: 10.1016/j.endien.2022.03.004
pii:
doi:

Substances chimiques

MC4R protein, human 0
Receptor, Melanocortin, Type 4 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-261

Informations de copyright

Copyright © 2022. Published by Elsevier España, S.L.U.

Auteurs

Lorena Mardones (L)

Laboratorio de Investigación en Ciencias Biomédicas, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Esteban Parra-Valencia (E)

Departamento de Ciencias Clínicas y Pre-Clínicas, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Fanny Petermann-Rocha (F)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

María Adela Martínez-Sanguinetti (MA)

Instituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.

Ana María Leiva-Ordoñez (AM)

Instituto de Anatomía, Histología y Patología, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile.

Nicole Lasserre-Laso (N)

Escuela de Nutrición y Dietética, Facultad de Salud, Universidad Santo Tomas, Región Metropolitana, Chile.

Miquel Martorell (M)

Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile; Departamento de Nutrición y Dietética, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile.

Natalia Ulloa (N)

Centro de Vida Saludable, Universidad de Concepción, Concepción, Chile; Departamento de Bioquímica Clínica e Inmunología, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile.

Eduardo Sanhueza (E)

Laboratorio de Investigación en Ciencias Biomédicas, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile.

Francisco Pérez-Bravo (F)

Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile.

Carlos Celis-Morales (C)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; Centro de Investigación en Fisiología del Ejercicio (CIFE), Universidad Mayor, Santiago, Chile; Laboratorio de Rendimiento Humano, Grupo de Estudio en Educación, Actividad Física y Salud (GEEAFyS), Universidad Católica del Maule, Talca, Chile.

Marcelo Villagrán (M)

Laboratorio de Investigación en Ciencias Biomédicas, Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción, Chile. Electronic address: marcelo.villagran@ucsc.cl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH